Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer?

Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer? Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer? Abstract Text:

Philipp von Bismarck,Karsten Klemm, ,Supandi Winoto-Morbach,Ulrike Uhlig,Stefan ,Stefan Uhlig,Burkhard Lachmann,Martin F Krause,

Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer? Publishing Authors By Initials

P von Bismarck,K Klemm,CF ,S Winoto-Morbach,U Uhlig,S ,S Uhlig,B Lachmann,MF Krause,

For similar chemical actions and uses: specialty uses of chemicals: surface-active agents research abstracts see: chemical actions and uses: specialty uses of chemicals: surface-active agents research

PUBMED ID PMID:

MEDLINE DATE:

Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer? Journal Published:

PUBLICATION TYPE: Editorial

Journal: Critical care medicine

VOLUME: 35

Page Numbers: 2442-3

Journal Abbreviation: Crit. Care Med.

ISSN: 0090-3493

DAY: 27

MONTH: Oct

YEAR: 2007

Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer? Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 355501

Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer? Keywords Mesh Terms:

KEYWORDS: Surface-Active Agents

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer? Information

Substance Name: protein kinase modulator

Registry Number: 0

Grant and Affiliation Information for Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer?

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Crit Care Med

REFSOURCE: Crit Care Med. 2007 Oct;35(10):2309-18

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer? Related Publications

• Death of a clinical trial: a speculative inclusion criterion gone wrong.
• Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis.
• Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer?
• The green tea polyphenol epigallocatechin-3-gallate improves systemic hemodynamics and survival in rodent models of polymicrobial sepsis.
• Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis.